Accord Healthcare announces a significant change to the way the UK receives hydroxychloroquine (HCQ), a medicine under investigation during COVID-19.
Read MoreThe Department of Health and Social Care (DHSC) announced yesterday, 16 April 2020 that the UK’s supplies of the vital muscle relaxant medicines (atracurium and cisatracurium) used in patients on mechanical ventilators will be exhausted in the next few days via the MHRA.
Read MoreOur team in Italy were asked by Medicines for Europe and the ASSOGENERICI (Italian G
Read MoreAccord Healthcare featured on the BBC
Read MoreAccord Healthcare Ltd is collaborating on a large multi-national study into the prevention of COVID-19 infection using hydroxychloroquine, a drug that may have an effect in preventing and/or reducing symptoms of COVID-19, in line with the WHO's targeted research priorities.
Read MoreOnline pharmacies are on the rise and their growth rate has doubled.
Read MorePutting patients at the heart is what we believe in at Accord.
Read MoreShowcasing our expertise around innovative growth, Accord recently partnered with Generics Bulletin and Scrip to host a round table of pharma professionals including Clinigen, Mylan, BC Partners and Medichem to discuss growth in the industry.
Read MoreAccord Fawdon recently hosted a special event to celebrate its supplier partnerships.
Read More